Last week, Daniel Donnan, a 21-year-old bowler from Ireland was diagnosed with testicular cancer after experiencing a dizzy spell while at the gym.
On Monday morning, he passed away.
Belfast Telegraph reported:
Tributes have been paid to a young Co Down bowler who died days after being diagnosed with testicular cancer.
Daniel Donnan from Donaghadee was taken to hospital after he suddenly fell ill towards the end of last week.
It’s understood he experienced a dizzy spell in the gym and numbness down one side of his body.
The 21-year-old was rushed to the Ulster Hospital where he was treated for a bleed to the brain, but medical tests revealed tumours which had already spread to his brain and lungs.
Dr. William Makis, a Canadian physician with expertise in Radiology, Oncology and Immunology, published a substack over the weekend that raised questions about a sudden onslaught of testicular cancer cases among young, otherwise healthy athletes and other physically fit men.
In Dr. Makis’s article, he points out a “fact check” that denies any link between testicular cancer and the experimental mRNA shot but does admit that four German footballers in the first league have gotten testicular cancer since 2022. Dr. Makis points to another article claiming that the number is actually as high as 14. He also notes that it’s rugby players, skiers, cricket players, and even a 32-year-old military member in California.
From Dr. Makis’ substack:
What is going on?
When a “fact check” vigorously denies something, it is very often true. Sure enough, a fact check denying the link between COVID-19 vaccines and testicular cancer exists (click here).
The fact check says “there is no evidence” but admits: “Grain of Truth: Four football players from the German first league have got testicular cancer since the spring of 2022.”
Except it’s not just 4 German football players (one article claims it’s actually 14). It’s also rugby players, skiers, cricket players, etc.
It’s athletes as well as non-athletes:
Some cases are extremely rapidly progressive, like this one: “late stage less than 2 months from 2nd jab…spread everywhere”.
Or in the case of 21 year old Irish cricket player Daniel Donnan, only a few days from diagnosis to death.
Or the case of VAERS 1232833 – a 32 year old military man who developed testicular pain 4 days after 2nd Pfizer COVID-19 mRNA dose and 20 days later was diagnosed with testicular cancer with metastatic spread to retroperitoneal lymph nodes.
What is the link between COVID-19 vaccines & testicular cancer?
As an Oncologist, I ask how and why. Yes, the COVID-19 vaccine spike protein localizes to the testes, according to the Japanese Pfizer Organ bio-distribution study done with rats. But at 48hr, the ovaries get 40x more LNP-mRNA than testes.
Pfizer/BioNTech have a testicular cancer treatment ready
Coincidentally, Pfizer’s COVID-19 mRNA vaccine partner BioNTech received European approval for new testicular cancer treatment on June 23, 2022, just as testicular cancer cases exploded across the German Bundesliga (click here).
Interestingly, their novel treatment targets heavily pretreated patients with relapsed or refractory advanced testicular cancer. In other words, particularly aggressive (turbo?) testicular tumors that don’t respond to conventional treatment.
Again, it’s almost as if they knew.
Wherever COVID-19 vaccine spike protein accumulates, we see a “spike” in cancers: bone marrow (leukemias), lymph nodes (lymphomas), liver, kidney, pancreas, ovaries, testes, breasts, colon, brain, spinal cord, thyroid gland and more.
There is undoubtedly a direct local effect by the vaccine spike protein on the tissues it accumulates in, this is not just a systemic effect of the mRNA circulating and affecting the overall immune system.
Oncologists cannot continue to turn a blind eye to these rapidly progressive cancers, or “turbo cancers” as they’ve come to be known. Sooner or later, doctors will have to face the reality that they may have recommended something unsafe to their patients that was catastrophically damaging to their bodies.